$343 Million is the total value of Lagoda Investment Management, L.P.'s 32 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 31.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
REGN | Sell | REGENERON PHARMACEUTICALS | $46,397,000 | -9.2% | 99,748 | -0.4% | 13.54% | +1.1% |
NVO | Buy | NOVO-NORDISK A Sadr | $36,488,000 | +1.5% | 672,721 | +2.5% | 10.65% | +13.1% |
ALXN | Buy | ALEXION PHARMACEUTICALS INC | $26,104,000 | -11.6% | 166,914 | +2.2% | 7.62% | -1.6% |
SGEN | Buy | SEATTLE GENETICS INC | $24,552,000 | -19.0% | 636,730 | +1.7% | 7.17% | -9.8% |
RNR | Buy | RENAISSANCERE HOLDINGS LTD | $23,049,000 | +14.2% | 216,790 | +9.0% | 6.73% | +27.2% |
BRKA | Sell | BERKSHIRE HATHAWAY INC DELcl a | $22,257,000 | -5.5% | 114 | -0.9% | 6.50% | +5.2% |
MACK | Buy | MERRIMACK PHARMACEUTICALS IN | $20,063,000 | -22.7% | 2,357,558 | +12.3% | 5.86% | -14.0% |
SNMX | Buy | SENOMYX INC | $18,761,000 | -13.2% | 4,206,491 | +4.3% | 5.48% | -3.4% |
GOOG | New | ALPHABET INC F/K/A GOOGLE INCcl c | $16,876,000 | – | 27,738 | +100.0% | 4.93% | – |
MON | Sell | MONSANTO CO NEW | $15,113,000 | -27.8% | 177,090 | -9.8% | 4.41% | -19.6% |
XON | New | INTREXON CORP | $13,279,000 | – | 417,569 | +100.0% | 3.88% | – |
DMRC | New | DIGIMARC CORP NEW | $11,740,000 | – | 384,304 | +100.0% | 3.43% | – |
GLW | Sell | CORNING INC | $10,920,000 | -28.9% | 637,846 | -18.1% | 3.19% | -20.8% |
PTC | Buy | PTC INC | $9,957,000 | -5.7% | 313,701 | +21.8% | 2.91% | +5.0% |
ALSN | Sell | ALLISON TRANSMISSION HLDGS I | $9,264,000 | -24.0% | 347,083 | -16.6% | 2.70% | -15.3% |
GOOGL | New | ALPHABET INC F/K/A GOOGLE INCcl a | $8,271,000 | – | 12,956 | +100.0% | 2.41% | – |
JNJ | Sell | JOHNSON & JOHNSON | $7,073,000 | -47.9% | 75,765 | -45.6% | 2.06% | -41.9% |
UBNT | New | UBIQUITI NETWORKS INC | $4,588,000 | – | 135,375 | +100.0% | 1.34% | – |
BRKB | Sell | BERKSHIRE HATHAWAY INC DELcl b new | $4,565,000 | -20.1% | 35,011 | -16.6% | 1.33% | -11.1% |
VRX | Sell | VALEANT PHARMACEUTICALS INTL | $4,286,000 | -24.0% | 24,025 | -5.4% | 1.25% | -15.4% |
ESGR | Buy | ENSTAR GROUP LIMITED | $3,794,000 | +0.1% | 25,294 | +3.4% | 1.11% | +11.5% |
MA | Buy | MASTERCARD INCcl a | $3,036,000 | -2.0% | 33,690 | +1.7% | 0.89% | +9.1% |
NJDCY | Sell | NIDEC CORPsponsored adr | $1,342,000 | -7.6% | 77,428 | -0.4% | 0.39% | +2.9% |
Y | Sell | ALLEGHANY CORP DEL | $300,000 | -2.3% | 640 | -2.3% | 0.09% | +10.0% |
GOLD | Sell | RANDGOLD RES LTDadr | $266,000 | -98.4% | 4,500 | -98.2% | 0.08% | -98.3% |
COP | Sell | CONOCOPHILLIPS | $81,000 | -26.4% | 1,699 | -5.6% | 0.02% | -17.2% |
PFE | PFIZER INC | $51,000 | -5.6% | 1,617 | 0.0% | 0.02% | +7.1% | |
XOM | EXXON MOBIL CORP | $53,000 | -10.2% | 715 | 0.0% | 0.02% | 0.0% | |
ABT | ABBOTT LABS | $26,000 | -16.1% | 640 | 0.0% | 0.01% | 0.0% | |
ABBV | ABBVIE INC | $27,000 | -18.2% | 491 | 0.0% | 0.01% | -11.1% | |
PSX | Sell | PHILLIPS 66 | $19,000 | -24.0% | 247 | -19.5% | 0.01% | -14.3% |
GSK | Sell | GLAXOSMITHKLINE PLCsponsored adr | $9,000 | -18.2% | 239 | -11.2% | 0.00% | 0.0% |
UTX | Exit | UNITED TECHNOLOGIES CORP | $0 | – | -93 | -100.0% | -0.00% | – |
AAPL | Exit | APPLE INC | $0 | – | -3,200 | -100.0% | -0.10% | – |
GOOGL | Exit | GOOGLE INCcl a | $0 | – | -14,686 | -100.0% | -2.08% | – |
HP | Exit | HELMERICH & PAYNE INC | $0 | – | -156,417 | -100.0% | -2.89% | – |
GOOG | Exit | GOOGLE INCcl c | $0 | – | -26,970 | -100.0% | -3.68% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
RENAISSANCERE HOLDINGS LTD | 36 | Q3 2023 | 10.4% |
ENSTAR GROUP LIMITED | 36 | Q3 2023 | 9.5% |
NOVO-NORDISK A S | 36 | Q3 2023 | 10.6% |
BERKSHIRE HATHAWAY INC DEL | 36 | Q3 2023 | 6.9% |
MASTERCARD INCORPORATED | 36 | Q3 2023 | 0.9% |
CONOCOPHILLIPS | 36 | Q3 2023 | 0.1% |
ABBOTT LABS | 36 | Q3 2023 | 0.1% |
PHILLIPS 66 | 36 | Q3 2023 | 0.0% |
PTC INC | 34 | Q3 2023 | 13.1% |
BERKSHIRE HATHAWAY INC DEL | 34 | Q3 2023 | 2.6% |
View Lagoda Investment Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
DIGIMARC CORP | February 14, 2019 | 226,177 | 1.9% |
T2 Biosystems, Inc.Sold out | February 14, 2019 | 0 | 0.0% |
SENOMYX INC | February 14, 2018 | 2,043,935 | 4.2% |
View Lagoda Investment Management, L.P.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
SC 13G/A | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
View Lagoda Investment Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.